Events

Rappel de RealTime HIV-1 Reagent

Selon L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), ce/cet/cette rappel concerne un dispositif en/au/aux/à France qui a été fabriqué par ABBOTT.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    R1713141
  • Date
    2017-08-18
  • Pays de l'événement
    France
  • Source de l'événement
    ANSM
  • URL de la source de l'événement
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/reactif-abbott-realtime-hiv-1-abbott-rappel-de-lots
  • Notes / Alertes
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Notes supplémentaires dans les données
  • Action
    ANSM has been informed of the implementation of a withdrawal of lots by Abbott. This safety action is registered at ANSM under the number R1713141. Read auss. Abbott RealTime HIV-1 Assay - lots 473470, 474215, 474890, 475025, 475532, 475694, 476172, 476356, 476736 and 476951 - letter (18/08/2017) (31 KB Abbott RealTime HIV-1 Test - lots 473470, 474215, 474890, 475025, 475532, 475694, 476172, 476356, 476736 and 476951 - form (18/08/2017) (21 KB Abbott RealTime HIV-1 Test - lots 473470, 474215, 474890, 475025, 475532, 475694, 476172, 476356, 476736, 476951 and 476139 - letter (18/08/2017) (35 kb Abbott RealTime HIV-1 Test - lots 473470, 474215, 474890, 475025, 475532, 475694, 476172, 476356, 476736, 476951 and 476139 - form (18/08/2017) (21 KB)

Device

RealTime HIV-1 Reagent
  • Modèle / numéro de série
  • Description du dispositif
    in-vitro_medical_device
  • Manufacturer
    ABBOTT

Manufacturer

ABBOTT
  • Société-mère du fabricant (2017)
    Abbott Laboratories
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    LAANSM